![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1
Department of Biology, York University, Toronto, Ontario, Canada
Brief exposure of the heart to hypoxia results in less cellular damage after subsequent hypoxia, an effect known as preconditioning (PC). PC has been widely studied but is still not fully understood. Adenosine (Ado), adenosine receptors, and protein kinase C (PKC) have been implicated as integral components of PC. Adenosine (nucleoside) transporters (NTs) facilitate flux of Ado across cell membranes, but their role in PC is unknown. Therefore, we used the murine cardiomyocyte cell line, HL-1, and asked if there was feedback regulation of NTs by Ado, Ado receptors, and PKC following either hypoxic or pharmacological PC. Activation (by specific agonists) of A1 or A3 Ado receptors or PKC resulted in PC in HL-1. The A1 (but not A3) receptor is coupled to PKC
, and activation of PKC
(by specific peptide agonist) resulted in PC. Moreover, PKC
stimulates Ado uptake via the predominant NT in HL-1, mouse equilibrative nucleoside transporter 1 (mENT1). Studies in primary neonatal mouse cardiomyocytes confirmed our observations in HL-1 cells. Hypoxic challenge led to a rapid increase in, and efflux of, intracellular Ado from cells, which was blocked by NT inhibitors (dipyridamole/nitrobenzylthioinosine). Moreover, NT inhibition during hypoxia or PC was highly protective, suggesting that Ado loss contributes to decreased cell viability. Our data suggest that hypoxic challenge causes an efflux of Ado via ENTs, activation of A1 and/or A3 receptors, signaling through PKC
, and activation of ENT1. Since Ado is required for ATP synthesis on reperfusion, this feedback regulation of mENT1 would promote reuptake of Ado.
Address correspondence to: Imogen R. Coe, Department of Biology, York University, 4700 Keele St., Toronto, Ontario, Canada M3J 1P3. E-mail: coe{at}yorku.ca
This article has been cited by other articles:
![]() |
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen Ethanol for cardiac ischemia: the role of protein kinase c Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 469 - 483. [Abstract] [PDF] |
||||
![]() |
Z. Naydenova, J. B. Rose, and I. R. Coe Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2687 - H2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Rose and I. R. Coe Physiology of Nucleoside Transporters: Back to the Future. . . . Physiology, February 1, 2008; 23(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patzak, E. Y. Lai, M. Fahling, M. Sendeski, P. Martinka, P. B. Persson, and A. E. G. Persson Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2232 - R2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eckle, A. Grenz, D. Kohler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2533 - H2540. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Valdes, W. Liu, B. Ullman, and S. M. Landfear Comprehensive Examination of Charged Intramembrane Residues in a Nucleoside Transporter J. Biol. Chem., August 11, 2006; 281(32): 22647 - 22655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gorlach Control of Adenosine Transport by Hypoxia Circ. Res., July 8, 2005; 97(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
C. J. Endres and J. D. Unadkat Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S6-(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole Mol. Pharmacol., March 1, 2005; 67(3): 837 - 844. [Abstract] [Full Text] [PDF] |
||||